Luminal A breast carcinoma
MONDO:0021116A biologic subset of breast carcinoma defined by high expression of genes characteristic of luminal epithelial cells, including estrogen receptor (ER), estrogen regulated protein LIV-1, and the transcription factors hepatocyte nuclear factor 3, HNF3A, XBP1, and GATA 3. This subtype of breast cancer is associated with a good prognosis.
Also known as: Luminal A, Luminal A breast cancer, Luminal A breast carcinoma, Luminal A estrogen receptor positive subtype of breast carcinoma, Luminal A oestrogen receptor positive subtype of breast carcinoma, Luminal A subtype of breast carcinoma
2807 clinical trials for this condition and its sub-types, 3 tagged with Luminal A breast carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Could a scan replace surgery for breast cancer staging?
Diagnosis Recruiting nowThis study tests whether a special PET/MRI scan can accurately detect if breast cancer has spread to lymph nodes in the armpit, potentially replacing the need for surgical removal of those nodes. About 119 women with certain types of breast cancer (luminal A or lobular) will get …
Phase 2 • Sponsor: Università Vita-Salute San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Scientists map fat and organelles in breast cancer cells to unlock subtype secrets
Knowledge-focused Recruiting nowThis study is collecting tumor samples from 1,050 people with early or metastatic breast cancer to analyze fat storage and organelle properties in cancer cells. Researchers aim to create a detailed atlas of these features across different breast cancer subtypes. The goal is to be…
Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC